Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults

StatusNot Yet Recruiting
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fields
  2. Study First Submitted
The purpose of this study is to evaluate the long-term safety of BR005-036C tablets in the acute treatment of migraines
Trial Details
NCT Number NCT07835152
Lead Sponsor Brise Pharmaceuticals Co., Ltd.
Conditions
(from sponsor)		 Migraine, With or Without Aura
Related terms Migraine Disorders
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov